The Development of Contextual Cognitive Behavioural Approach to PDN
1 other identifier
interventional
30
1 country
2
Brief Summary
Diabetes mellitus (DM) is highly prevalent, and a significant public health problem. Approximately 25-30% of all individuals with DM develop painful diabetic neuropathy (PDN). PDN is considered a complex, multi-dimensional condition, possibly affecting the physical and mental health of the individual. PDN is usually described as a sense of burning, stabbing, aching and/or pricking mainly affecting areas like toes, legs, and feet and physically interfering with mobility, sleep, mood, and overall quality of life. This condition represents both a significant problem in its own right and a useful condition in which to test treatments that may offer wider benefits for neuropathic pain conditions in general. A relatively new and promising approach to chronic pain, within the wider range of cognitive and behavioural approaches, is Acceptance and Commitment Therapy (ACT). ACT is a form of Cognitive Behavioural Therapy (CBT) that focuses specifically on increasing psychological flexibility. Psychological flexibility is the capacity to change or continue with a behaviour, depending on which is more effective, according to one's goals and what the current situation affords. Psychological flexibility in turn includes processes of acceptance, values-based action, and other processes related to mindfulness. There are no published studies of ACT for individuals with PDN, and the limited available evidence indicates that a CBT-based intervention like ACT has the potential to reduce pain in people with PDN. People with PDN have clear treatment needs. While ACT may help them, little is known directly about the relevance of different components of ACT for this condition or about how to customise it for them. The proposed research aims to conduct a small feasibility trial which will pilot test a psychological treatment for PDN and assess the feasibility, acceptability and effectiveness of such a treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Oct 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 3, 2018
CompletedFirst Posted
Study publicly available on registry
October 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedOctober 9, 2018
October 1, 2018
1 year
October 3, 2018
October 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Committed Action Questionnaire (CAQ-8)
The CAQ-8 is an eight-item measure of committed action, a facet of PF. Committed action is the ability to persist with actions that are guided by goals, including when this runs into discouraging experiences and to change these actions when they are shown to be ineffective. Responses to the items were rated from 0 (never true) to 6 (always true). Out of the eight items four are positively keyed and four negatively keyed.
8 weeks
Secondary Outcomes (7)
Cognitive Fusion Questionnaire (CFQ-7)
8 weeks
Chronic Pain Acceptance Questionnaire (CPAQ-8)
8 weeks
Douleur neuropathique 4 (DN4)
8 weeks
Pain Scale
8 weeks
Patient Health Questionnaire (PHQ-9)
8 weeks
- +2 more secondary outcomes
Study Arms (1)
Intervention
EXPERIMENTALThis is a single-cohort ACT based intervention.
Interventions
The process will involve, two, brief, one-to-one contact sessions, one at the beginning and one at the end of the intervention, in a way that is convenient for participants, including Skype, phone, or face to face in person. Following the first one-to-one session there will be eight short online sessions, about 20-30 minutes each. Participants will also be asked to complete some tasks between the sessions, in particular to record their progress briefly and any changes at their medication (i.e. type of drug, dose) in a diary weekly so that they can keep track of your developing skills.
Eligibility Criteria
You may qualify if:
- Aged at least 18 years.
- Confirmed diagnosis of diabetes.
- Presence of painful diabetic neuropathy.
- Have full verbal and written proficiency in English.
- Willingness and ability to take part.
- Have computer literacy.
You may not qualify if:
- Not understanding verbal explanation or written information in English.
- Suffering from neuropathy due to other causes than diabetes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- Diabetes UKcollaborator
Study Sites (2)
St Thomas' NHS Foundation Trust (Diabetes Clinic)
London, SE1 7EH, United Kingdom
Guy's hospital NHS Foundation Trust (Diabetes Clinic)
London, SE1 9RT, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2018
First Posted
October 9, 2018
Study Start
October 1, 2018
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
October 9, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share
King's College London (KCL) and Guy's and St Thomas' NHS Foundation trust (GSTT) are the co-sponsors for this study based in the United Kingdom. They will be using information from participants in order to undertake this study and will act as the data controller for this study. This means that they are responsible for looking after participants' information and using it properly. King's College London and Guy's and St Thomas' NHS Foundation trust will keep identifiable information about participants for 7 years after the study has finished. Participants rights to access, change or move information are limited, as KCL and GSTT need to manage participants information in specific ways in order for the research to be reliable and accurate. If participants withdraw from the study, KCL and GSTT will keep the information about them that have already been obtained. To safeguard participants rights, KCL and GSTT will use the minimum personally-identifiable information possible.